Kyle's Board

[kyle_anderson]

VGLS getting a promotion starting January 14, 2013 @ 5:10 PM

Some quick due diligence for VG Life Sciences Inc.

Float: 2,609,624 shares as of September 30, 2012
O/S: 3,174,672 shares as of November 27, 2012
A/S: 60,000,000 shares as of November 27, 2012

Market tier: OTC Pink Current
Market Capitalization: $1,110,818

The promoter for this "investor awareness" campaign is "Liquid Pennies". These are the last few stocks (ordered by promotion start date) that "Liquid Pennies" has campaigned for and the closing share price for that day and stock

1. TAEC - Todays Alternative Energy Corp.
The end of day closing price for TAEC on the first day of that promotion (Jan. 9, 2013), was 0.016 which was a gain of 24.00%.

2. CHLO - China Logistics Group, Inc.
The end of day closing price for CHLO on the first day of that promotion (Jan. 7, 2013), was 0.045 which was a gain of 1566.67%.

3. IEAG - Iron Eagle Group, Inc.
The end of day closing price for IEAG on the first day of that promotion (Dec. 14, 2012), was 0.240 which was a gain of 26.32%.

This is one of the newsletters I got (at 5:10 PM CST) in my inbox:

You are receiving this free stock alert email because you have signed up at LiquidPennies.com

If you no longer wish to receive winning stock picks from us, at the bottom of every email sent from our system, there is a Manage Subscription link where you may unsubscribe at any time.

Thank you for being a valued member and Happy Trading

Put VGLS on your radar NOW

We literally JUST came across this stock and it's too good not to share

VGLS just recently hit a 52 week low of .19 and has been heading north over the last few trading days

VGLS is on a bullish upswing closing at .37 this past session

Volume has also been picking up consistently coinciding with two major press releases in the last week.

In addition, VGLS was trading north of $1.00 as recently as October

A retrace to previous levels could mean 100% returns

Did I mention VGLS has a float of only about $965k

As always, ideal trade opportunities come when maximum upside potential meets minimal downside, and both are evident in VGLS

About the company

San Marino, California-based VG Life Sciences Inc.VGLS, formerly known as Viral Genetics, discovers and develops drug therapies from two exclusively licensed platform technologies based upon its holdings of over 60 patents including Metabolic Disruption MDT and Targeted Peptides TPT.

VGLS' recent symbol and name change reflect the companys evolution from RD to Active Clinical Trials at Baylor Scott White Health and Broader High Growth Life Sciences operations.

A physician-initiated Phase I clinical trial of an MDT compound in combination with Nexavar on Stage III and IV ovarian cancer patients is ongoing at the Cancer Therapy and Research Center of The University of Texas Health Science Center at San Antonio.

VGLS has just received approval from the Institutional Review Board of the University of Texas Health Science Center San Antonio to expand the types of cancers being studied in the Company's ongoing physician-initiated Phase 1 clinical trial.

The IRB action allows the study to immediately broaden scope to the treatment of all solid tumors, which includes a wide and diverse range of cancer types including breast, colon, lung, liver and pancreas cancer.

Effective immediately, principal investigator Dr. Tyler Curiel will begin screening patients with all solid tumors to study the safety of hydroxychloroquine HCQ in combination with sorafenib marketed as Nexavar by Bayer AG.

Dr. Tyler Curiel, the lead investigator, said, We now have approval to use sorafenib and HCQ to treat all solid tumors. I have identified candidate patients for this expanded protocol, and we are continuing screening for potential enrollment.

Dr. Curiel is an internationally recognized expert and speaker in tumor immunology and in the humanities, has been a featured scientist on the NOVANow Science Television program on PBS.

Dr. Curiel is also the recipient of numerous medical and civic service awards including

-The Mauveny Prize for Cancer Research from Tulane University

-The STARS Research Enhancement Award from the University of Texas

and

-The Health Care Hero Award from the San Antonio Business Journal

Dr. Curiel holds membership in a multitude of professional organizations and sits on the Editorial Boards of several publications including The Journal of Immunology and The Journal of Clinical Investigation.

VGLS holds the exclusive worldwide license to the body of patents underlying the use of MDT compounds in the treatment of cancers.

In addition, majority-owned subsidiary VG Energy is dedicated to exploring biofuel and agricultural applications for the MDT platform.

VGLS is researching treatments for drug-resistant cancer, Lyme disease, Strep, Staph and Sepsis, and HIVAIDS.

Check out VGLS' chart below

Read all VGLS' current news here

You may continue your research at

and

and make sure VGLS gets your FULL ATTENTION ASAP

Please read carefully before using any information contained in this email

Liquid Pennies has a no tolerance spam policy, we will not sell or re distribute your email to any 3rd party. If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members. Verify all claims and do your own due diligence. Liquid Pennies profiles are not a solicitation or recommendation to buy, sell or hold securities. Liquid Pennies is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Liquid Pennies is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17b, Liquid Pennies is owned and operated by Stock Appeal LLC. Neither Stock Appeal LLC. nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Liquid Pennies receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Liquid Pennies statements and opinions and such statements and opinions cannot be considered independent. Liquid Pennies and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains forward looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be forward looking statements. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. This publication is a free service of Stock Appeal LLC, a financial public relations firm that is sometimes compensated by companies it profiles. Currently, Stock Appeal LLC has been compensated up to $10,000 USD for increased pubic awareness of VGLS by Lake Group Media, a third party. It is to be assumed that one or more third parties as well as current shareholders may have shares and may choose to liquidate them at or about the same time these services are performed, which may negatively affect the stock price. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled companies. All direct and third party compensation received is and will be fully disclosed in any communication regarding a profiled company.

Additional Compensation and Other Disclosures

The content of this message is published by BLUEWATER ADVISORY, LLC and sent to select email lists through Lake Group Media, Inc. Lake to provide readers with information on selected publicly traded companies. Factual information is obtained from public filings and other sources deemed to be reliable however, neither BLUEWATER ADVISORY, LLC nor Lake takes responsibility for verifying the accuracy of such information and they make no representation that such information is accurate or complete. Certain of the statements in this Update may be considered forwarded looking statements. BLUEWATER ADVISORY, LLCand Lake make no representation and provide no assurance or guaranty that such forward looking statements will prove to be accurate. See the companys filings with the Securities and Exchange Commission for factors that may cause results to be significantly different. Statements of opinion and belief are those of the authors andor editors of this Update, and are based solely upon the information possessed by such authors andor editors no inference should be drawn that such authors or editors have any special or greater knowledge about the company or companies profiled or any particular expertise in the industries or markets in which the profiled company or companies compete. The reader should verify all claims and complete his own due diligence before investing in any securities of the profiled company or companies. Neither BLUEWATER ADVISORY, LLC, Lake, nor anyone involved in the publication or dissemination of this Update is a registered investment adviser or brokerdealer. BLUEWATER ADVISORY, LLC and Lake make no recommendation that the purchase of securities of the company or companies profiled in this Update are suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the company or companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. An investor in such securities should be prepared and able to bear a loss of his or her entire investment. Nothing in this Update should be construed as an offer or solicitation to buy or sell any securities of any profiled company. Lake has been retained to provide direct marketing services for the company profiled in this Update and receives compensation for those services. Further, Lake and its employees and affiliates may own, or may purchase and sell, securities of the company or companies profiled. Lake undertakes no obligation to inform readers about the ownership or trading activities of it or its employees or affiliates in the securities of the profiled company or companies. Lake has the following compensation arrangements with the company or companies profiled in this Update Lake receives an advertising fee ranging from $1,000 to $100,000 for each direct marketing list recommended and ordered for the dissemination of this Update.

This message was sent to from

Stock Appeal LLC P.O. Box 448 North Chili, NY 14514

Email Marketing by

If you would like to see the promotion performance history for this promoter, you can visit my board and view a similar but more detailed post there.

I use custom software that tracks all major stock promotions and keeps records of their performances. I am NOT affiliated with any stock promoter and I provide this information as a courtesy to supplement your own due diligence.